Halozyme Therapeutics | Ativos

Assets Alterar Data
Acadia Pharmaceuticals USD 748.96M 116.42M 2023-12
Agios Pharmaceuticals USD 937.12M 70.14M 2023-12
Alnylam Pharmaceuticals USD 3.83B 9.19M 2023-12
Amarin USD 839.03M 20.99M 2023-09
Amgen USD 97.15B 6.62B 2023-12
Baxter International USD 28.28B 2.38B 2023-12
Cytokinetics USD 824.32M 83.7M 2023-12
Eli Lilly USD 57.92B 3.1B 2023-09
Halozyme Therapeutics USD 1.73B 159.39M 2023-12
Intra Cellular Therapies USD 728.3M 10.63M 2023-12
Ionis Pharmaceuticals USD 2.99B 56.1M 2023-12
MannKind USD 475.2M 154.87M 2023-12
Pfizer USD 215.02B 5.15B 2023-09
United Therapeutics USD 7.17B 143.4M 2023-12



Halozyme Therapeutics Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2024.